Goldman Sachs Group Inc Aytu Biopharma, Inc Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.46 - $1.08 $23,067 - $54,157	-50,146 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.08 - $1.55 $10,021 - $14,382	9,279 Added 22.71%	50,146 $54,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $10,430 - $22,791	-7,726 Reduced 15.9%	40,867 $55,000
Q3 2021 Nov 10, 2021	BUY	$2.78 - $5.12 $135,088 - $248,796	48,593 New	48,593 $140,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.